PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+19.67%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$117M
AUM Growth
+$117M
(+16%)
Cap. Flow
+$1.02M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
40.41%
Holding
101
New
3
Increased
31
Reduced
35
Closed
9
Top Buys
| 1 |
Airgain
AIRG
|
$1.3M |
| 2 |
Digital Turbine
APPS
|
$1.28M |
| 3 |
Elutia
ELUT
|
$932K |
| 4 |
Village Farms International
VFF
|
$760K |
| 5 |
Rockwell Medical
RMTI
|
$519K |
Top Sells
| 1 |
Perion Network
PERI
|
$1.14M |
| 2 |
Journey Medical
DERM
|
$1.11M |
| 3 |
Perspective Therapeutics
CATX
|
$791K |
| 4 |
Achieve Life Sciences
ACHV
|
$538K |
| 5 |
Fortress Biotech
FBIO
|
$408K |
Sector Composition
| 1 | Healthcare | 50% |
| 2 | Technology | 27.44% |
| 3 | Industrials | 10.52% |
| 4 | Communication Services | 6.23% |
| 5 | Consumer Staples | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
ePlus
PLUS
$1.85B
| $719K | 0.61% |
9,000
-500
| -5% | -$39.9K |
|
52
Castle Biosciences
CSTL
$673M
| $694K | 0.59% |
32,140
+2,980
| +10% | +$64.3K |
|
|
53
Rockwell Medical
RMTI
$59.6M
| $661K | 0.56% |
349,934
+274,891
| +366% | +$519K |
|
54
AT&T
T
$208B
| $655K | 0.56% |
39,042
+2,500
| +7% | +$41.9K |
|
55
US Bancorp
USB
$75.5B
| $649K | 0.55% |
14,984
| – | – |
|
56
Verizon
VZ
$184B
| $626K | 0.53% |
16,617
+1,500
| +10% | +$56.5K |
|
57
Fastenal
FAST
$56.8B
| $622K | 0.53% |
9,600
| – | – |
|
58
Donaldson
DCI
$9.28B
| $581K | 0.5% |
8,884
-1,000
| -10% | -$65.4K |
|
59
NXP Semiconductors
NXPI
$57.5B
| $563K | 0.48% |
2,450
| – | – |
|
60
Apyx Medical
APYX
$71.9M
| $559K | 0.48% |
213,500
+1,700
| +0.8% | +$4.45K |
|
61
ANI Pharmaceuticals
ANIP
$2.06B
| $507K | 0.43% |
9,191
| – | – |
|
|
AKTS
62
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $506K | 0.43% |
606,652
+9,152
| +2% | +$7.63K |
|
63
BioLife Solutions
BLFS
$1.2B
| $504K | 0.43% |
31,000
| – | – |
|
64
LifeVantage
LFVN
$171M
| $457K | 0.39% |
76,113
| – | – |
|
65
CVS Health
CVS
$93B
| $457K | 0.39% |
5,793
+500
| +9% | +$39.4K |
|
66
Option Care Health
OPCH
$4.7B
| $371K | 0.32% |
11,000
-1,500
| -12% | -$50.6K |
|
67
Moderna
MRNA
$9.36B
| $368K | 0.31% |
+3,700
| New | +$368K |
|
68
BP
BP
$88.8B
| $366K | 0.31% |
10,350
+3,200
| +45% | +$113K |
|
69
Johnson & Johnson
JNJ
$429B
| $353K | 0.3% |
2,250
| – | – |
|
70
Shimmick
SHIM
$102M
| $343K | 0.29% |
+52,000
| New | +$343K |
|
71
Asure Software
ASUR
$220M
| $314K | 0.27% |
33,000
| – | – |
|
|
IMGN
72
DELISTED
Immunogen Inc
IMGN
| $308K | 0.26% |
10,400
-1,700
| -14% | -$50.3K |
|
73
RingCentral
RNG
$2.74B
| $306K | 0.26% |
9,025
-2,500
| -22% | -$84.8K |
|
74
Ionis Pharmaceuticals
IONS
$9.64B
| $281K | 0.24% |
5,550
| – | – |
|
|
75
Perspective Therapeutics
CATX
$251M
| $281K | 0.24% |
700,000
-1,971,644
| -74% | -$791K |
|